Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 183 participants.
Also called NCT01030458
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 183 participants
- Sponsor
- Registry
-
NCT01030458
-
- Main results
- Efficacy of newer versus older antihypertensive drugs in black patients living in sub-Saharan Africa
- Other papers using this trial's data
- Heart rate variability on antihypertensive drugs in black patients living in sub-Saharan Africa
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Cameroon, Côte d’Ivoire, Gabon, Nigeria, Senegal
- Registry status
- Completed
Technical summary
Registry record NCT01030458. Randomized; no masking; primary purpose treatment. Start 2010-09 (registry gives no type); primary completion 2012-03 (actual). Results posted on 2013-11-15.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) Trial
- Acronym
- NOAAH
- Condition
- Blood Pressure
- Intervention (Drug)
- amlodipine 5/10 mg per day plus valsartan 160 mg/day
- Intervention (Drug)
- hydrochlorothiazide 6.25 mg/day plus bisoprolol 5/10 mg/day
- Lead sponsor
- KU Leuven
- Collaborator
- University of Kinshasa
- Collaborator
- Yaounde Central Hospital
- Collaborator
- University of Yaounde
- Collaborator
- University of Libreville
- Collaborator
- Institute of Cardiology Abidjan
- Collaborator
- University of Ilorin Teaching Hospital
- Collaborator
- University of Nigeria, Enugu Campus
- Collaborator
- Hospital Aristide Le Dantec, Dakar, Senegal
Record details
- Record id
cardio:ct-nct01030458- Content hash
b0032f09edad13f6c1e66e69cf73efdd37dd073672a6cf47c48fbf1d2417e46b